| Study Phase | Number of Studies |
|---|---|
| 296014 | |
| PHASE2 | 57034 |
| PHASE1 | 42353 |
| PHASE3 | 37940 |
| PHASE4 | 32135 |
| PHASE1|PHASE2 | 14555 |
| PHASE2|PHASE3 | 6758 |
| EARLY_PHASE1 | 5009 |
Data in motion
In the realm of clinical trials, the distribution of study phases plays a crucial role in advancing medical research. With a staggering 296,014 studies falling under an unspecified phase, the landscape is vast and varied. Among the specified phases, PHASE2 takes the lead with 19% of the total studies, followed by PHASE1 at 14% and PHASE3 at 13%. The data also reveals interesting combinations like PHASE1|PHASE2 and PHASE2|PHASE3, showcasing the complexity of modern research methodologies. However, it's worth noting the absence of data for certain phases, hinting at potential gaps in the current understanding of clinical trial progression.
Trend in Clinical Trials Initiated in the US Over the Last Three Years
Trend of Clinical Trials Over the Last 10 Years
Comparison of Clinical Trials in Canada vs United States Over the Years
Trend in Clinical Trials Initiated in Singapore Over the Last Three Years
Total Enrollment in Phase I, II, and III for the Year 2024
Trend in Number of Phase III Trials Initiated from 2021 to 2023
Top 10 Sponsors with the Most Studies
Trends in Study Completion Over Time
Count of Oncology Trials Starting in the Next 3 Months
HbA1c Improvement Observed with BASAGLAR in Type 2 Diabetes Patients
Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years
Top Pharmaceutical Companies by Number of Trials Published in the Last 5 Years